Liquidia Technologies has started early clinical testing of its first vaccine developed using nanotechnology.
The Durham company, which has raised $25 million in financing this year, is testing a seasonal flu vaccine aimed at adults over age 65.
Liquidia is also developing cancer treatments and other products based on the nanotechnology research of founder Joseph DeSimone, a chemist at N.C. State University and UNC-Chapel Hill.
The flu vaccine will require years of clinical testing before it can win marketing approval from U.S. regulators. The vaccine is designed to have tiny particles deliver the medicine more safely and effectively.
Get the biggest news in your email or cellphone as it's happening. Sign up for breaking news alerts.
The maker of Tide Pods will create a new double-latch lid to deter children from accessing and eating the brightly colored detergent packets, a company spokesman said Friday. 
Another round of U.N. climate talks closed without resolving how to share the burden of curbing man-made global warming, mainly because countries don't agree on who is rich and who is poor. 
Australia and South Africa will share hosting of a giant radio telescope made up of thousands of separate dishes and intended to help scientists figure out the make-up of the universe, the international consortium overseeing the project announced Friday. 
The private company SpaceX made history Friday with the docking of its Dragon capsule to the International Space Station, the most impressive feat yet in turning routine spaceflight over to the commercial sector. Keep up with the latest stories with our free local news e-mail newsletters, delivered straight to your inbox!
Subscribe to Afternoon Update - it's free!
Subscribe to Breaking News - it's free!
Subscribe to Local & State News - it's free!
Subscribe to Today at a Glance - it's free!
Subscribe to Crime & Safety - it's free!
Subscribe to Education - it's free!
Subscribe to Health & Science - it's free!
